IOL CHEMICALS & PHARM. | BLISS GVS PHARMA | IOL CHEMICALS & PHARM./ BLISS GVS PHARMA |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.5 | 13.3 | 102.1% | View Chart |
P/BV | x | 1.5 | 1.4 | 113.0% | View Chart |
Dividend Yield | % | 1.0 | 0.4 | 230.4% |
IOL CHEMICALS & PHARM. BLISS GVS PHARMA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
BLISS GVS PHARMA Mar-23 |
IOL CHEMICALS & PHARM./ BLISS GVS PHARMA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 91 | 587.5% | |
Low | Rs | 272 | 67 | 404.5% | |
Sales per share (Unadj.) | Rs | 377.6 | 72.2 | 523.3% | |
Earnings per share (Unadj.) | Rs | 23.7 | 7.4 | 321.7% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 9.2 | 344.5% | |
Dividends per share (Unadj.) | Rs | 4.00 | 0.50 | 800.0% | |
Avg Dividend yield | % | 1.0 | 0.6 | 156.9% | |
Book value per share (Unadj.) | Rs | 256.8 | 84.0 | 305.7% | |
Shares outstanding (eoy) | m | 58.71 | 104.15 | 56.4% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 1.1 | 97.4% | |
Avg P/E ratio | x | 17.1 | 10.8 | 158.5% | |
P/CF ratio (eoy) | x | 12.8 | 8.7 | 148.0% | |
Price / Book Value ratio | x | 1.6 | 0.9 | 166.8% | |
Dividend payout | % | 16.9 | 6.8 | 248.7% | |
Avg Mkt Cap | Rs m | 23,743 | 8,262 | 287.4% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 862 | 195.2% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 7,516 | 295.0% | |
Other income | Rs m | 256 | 178 | 144.0% | |
Total revenues | Rs m | 22,427 | 7,694 | 291.5% | |
Gross profit | Rs m | 2,257 | 1,173 | 192.3% | |
Depreciation | Rs m | 462 | 187 | 247.2% | |
Interest | Rs m | 165 | 104 | 158.9% | |
Profit before tax | Rs m | 1,887 | 1,061 | 177.9% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 293 | 168.8% | |
Profit after tax | Rs m | 1,391 | 767 | 181.3% | |
Gross profit margin | % | 10.2 | 15.6 | 65.2% | |
Effective tax rate | % | 26.2 | 27.7 | 94.9% | |
Net profit margin | % | 6.3 | 10.2 | 61.5% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 6,974 | 138.6% | |
Current liabilities | Rs m | 5,025 | 1,933 | 260.0% | |
Net working cap to sales | % | 20.9 | 67.1 | 31.2% | |
Current ratio | x | 1.9 | 3.6 | 53.3% | |
Inventory Days | Days | 43 | 39 | 112.0% | |
Debtors Days | Days | 8 | 1,871 | 0.4% | |
Net fixed assets | Rs m | 11,017 | 4,562 | 241.5% | |
Share capital | Rs m | 587 | 104 | 563.7% | |
"Free" reserves | Rs m | 14,490 | 8,646 | 167.6% | |
Net worth | Rs m | 15,077 | 8,750 | 172.3% | |
Long term debt | Rs m | 0 | 407 | 0.0% | |
Total assets | Rs m | 20,684 | 11,535 | 179.3% | |
Interest coverage | x | 12.5 | 11.2 | 110.9% | |
Debt to equity ratio | x | 0 | 0 | 0.0% | |
Sales to assets ratio | x | 1.1 | 0.7 | 164.5% | |
Return on assets | % | 7.5 | 7.6 | 99.6% | |
Return on equity | % | 9.2 | 8.8 | 105.2% | |
Return on capital | % | 13.6 | 12.7 | 107.0% | |
Exports to sales | % | 26.7 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | 5,930 | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 5,930 | 5,618 | 105.5% | |
Fx outflow | Rs m | 6,052 | 1,225 | 494.2% | |
Net fx | Rs m | -122 | 4,394 | -2.8% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | 343 | 356.3% | |
From Investments | Rs m | -1,200 | -78 | 1,548.2% | |
From Financial Activity | Rs m | -41 | -249 | 16.5% | |
Net Cashflow | Rs m | -18 | 30 | -60.9% |
Indian Promoters | % | 48.2 | 35.0 | 137.8% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 1.7 | 21.3 | 8.0% | |
FIIs | % | 1.4 | 14.7 | 9.5% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 65.0 | 79.7% | |
Shareholders | 130,003 | 45,157 | 287.9% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | BLISS GVS PHARMA | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 1.64% | -1.34% | -0.57% |
1-Month | 4.77% | 2.89% | 0.07% |
1-Year | -0.25% | 46.72% | 52.18% |
3-Year CAGR | -13.23% | 3.93% | 14.04% |
5-Year CAGR | 16.12% | -7.86% | 19.13% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the BLISS GVS PHARMA share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of BLISS GVS PHARMA the stake stands at 35.0%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of BLISS GVS PHARMA.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
BLISS GVS PHARMA paid Rs 0.5, and its dividend payout ratio stood at 6.8%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of BLISS GVS PHARMA.
For a sector overview, read our pharmaceuticals sector report.
Indian share markets continued the momentum as the session progressed and ended the higher.